Rite Aid Allergy Relief Fexofenadine Tablets Recalled for Impurity
Rite Aid Allergy Relief Fexofenadine Hydrochloride 60mg tablets are being recalled due to failed impurity specifications detected during stability testing. The affected product was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving an out-of-specification impurity detected during stability testing. No illnesses or injuries have been reported in the source text, and the hazard is quality-control related rather than an acute safety threat, supporting a Moderate severity score.
Plain-English summary
Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 12HR, 60mg antihistamine in 24-count bottles are being recalled nationwide. The manufacturer, Perrigo Company PLC, identified an out-of-specification result for impurity A during stability testing.
The recalled lot numbers are 0JE2487 (expiration 01/31/2022) and 0ME2515 (expiration 04/30/2022), manufactured in the Czech Republic and distributed by Rite Aid from their Camp Hill, Pennsylvania location. Approximately 79,776 containers were affected.
Consumers who have purchased this product should stop using it. If you have questions or concerns about this recall, contact Rite Aid or consult your healthcare provider.
The recalled product
- Product
- Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistamine, 24 count bottle, Made in the Czech Republic, Distributed by Rite Aid 30 Hunter Lane Camp Hill PA 17011 NDC 11822-0425-0 UPC 0 11822 85410 8
- Manufacturer
- Perrigo Company PLC
- Hazard
- impurity
- degradation
- failed-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot # 0JE2487
- EXP 01/31/2022
- 0ME2515
- Exp 04/30/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27